Washington, DC (February 9, 2026) — The American Pharmacists Association (APhA) has selected the recipients of the 2026 APhA Immunization Champion Awards, recognizing outstanding individuals, pharmacy professionals, teams, and organizations that have made extraordinary contributions to improving vaccination access, delivery, and public health outcomes in communities across the nation.

WASHINGTON, DC (February 3, 2026) — Today, Congress passed funding legislation that includes long-sought federal PBM reforms, supported by the American Pharmacists Association (APhA), which are set to be signed into law. These provisions mark meaningful progress toward strengthening pharmacy reimbursement in Medicare and will help pharmacies sustainably dispense medications.

Washington, DC (December 18, 2025) – The American Pharmacists Association (APhA) participated in a White House ceremony marking the rescheduling of marijuana as a Schedule III drug. Marijuana’s Schedule I classification imposes strict regulatory requirements that make it difficult for researchers and scientists to obtain it for study. APhA believes that moving marijuana to Schedule III will help accelerate research into its medicinal applications and potentially lead to safer and more effective therapeutic uses.

Washington, DC (December 10, 2025)  — The American Pharmacists Association (APhA) is proud to announce that Thomas E. Menighan, BSPharm, MBA, ScD, has been selected as the 2026 Remington Honor Medal recipient. This accolade is widely recognized as the highest honor in the field of pharmacy. 

Washington, DC (December 4, 2025) The American Pharmacists Association (APhA) is deeply disappointed by today’s vote by the CDC’s Advisory Committee on Immunization Practices (ACIP) to remove the universal recommendation for administering the hepatitis B vaccine birth dose for infants born in the United States. This reversal rolls back a highly effective, evidence-based public health measure that has been in place since 1991.